Back to Search
MICHAEL QUON, M.D.
M.D.
Gastroenterology Physician
NPI: 1609802032IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
G63134(CA)
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
G63134(CA)
Education
OTHER
Class of 1986
Research & Publications (20)
Are statins effective for simultaneously treating dyslipidemias and hypertension?
PMID 17662294·Atherosclerosis·2008
6-review
Additive beneficial effects of atorvastatin combined with amlodipine in patients with mild-to-moderate hypertension.
PMID 19651449·Int J Cardiol·2011
2-rct
Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs.
PMID 19059660·Int J Cardiol·2010
2-rct
Does reversal of oxidative stress and inflammation provide vascular protection?
PMID 19098298·Cardiovasc Res·2009
6-review
Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes.
PMID 19394939·Atherosclerosis·2009
2-rct
Letter by Koh and Quon regarding article, "Evidence mandating earlier and more aggressive treatment of hypercholesterolemia".
PMID 19332476·Circulation·2009
8-other
Endothelial dysfunction in mice with streptozotocin-induced type 1 diabetes is opposed by compensatory overexpression of cyclooxygenase-2 in the vasculature.
PMID 18845644·Endocrinology·2009
4-observational
Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta}.
PMID 19406747·J Biol Chem·2009
7-preclinical
Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients.
PMID 18977478·Atherosclerosis·2009
4-observational
Treatment of spontaneously hypertensive rats with rosiglitazone ameliorates cardiovascular pathophysiology via antioxidant mechanisms in the vasculature.
PMID 19531637·Am J Physiol Endocrinol Metab·2009
7-preclinical
Targeting converging therapeutic pathways to overcome hypertension.
PMID 19136168·Int J Cardiol·2009
8-other
C-reactive protein inhibits insulin activation of endothelial nitric oxide synthase via the immunoreceptor tyrosine-based inhibition motif of FcgammaRIIB and SHIP-1.
PMID 19423845·Circ Res·2009
7-preclinical
The importance of considering alternative or combination strategies for lowering LDL-C.
PMID 19345431·Int J Cardiol·2009
8-other
Leptin and cardiovascular disease: response to therapeutic interventions.
PMID 18574061·Circulation·2008
6-review
Consequences of lipid droplet coat protein downregulation in liver cells: abnormal lipid droplet metabolism and induction of insulin resistance.
PMID 18487449·Diabetes·2008
7-preclinical
An integrated view of insulin resistance and endothelial dysfunction.
PMID 18775359·Endocrinol Metab Clin North Am·2008
6-review
Dehydroepiandrosterone stimulates phosphorylation of FoxO1 in vascular endothelial cells via phosphatidylinositol 3-kinase- and protein kinase A-dependent signaling pathways to regulate ET-1 synthesis and secretion.
PMID 18718910·J Biol Chem·2008
7-preclinical
Combination therapy for treatment or prevention of atherosclerosis.
PMID 18574065·Hypertension·2008
8-other
Cocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension.
PMID 19064532·Am J Clin Nutr·2008
2-rct
S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2.
PMID 18952604·J Biol Chem·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 23928 LYONS AVE, SUITE 206
NEWHALL, CA 91321 - Phone
- (661) 799-0615
Quick Facts
- NPI
- 1609802032
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 40
- Publications
- 20
Are you this provider?
Claim Your Profile